Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Pfizer (PFE)’

PERSHING SQUARE

Bill Ackman and Scott Ferguson Are Investing In The Same Stocks

At first glance, it doesn’t seem like fund managers Bill Ackman and Scott Ferguson are all that much alike. Except for the obvious facts that they are......(read more)
CITADEL INVESTMENT GROUP

Billionaire Ken Griffin Thinks Apple Inc. (AAPL) Is Cheap. What About His Other Picks?

Many investors and market watchers claim that quarterly 13Fs from hedge funds are of limited use to mom-and-pop traders. However, we have done extensive......(read more)
MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (MNKD): What’s the Latest: New Insulin Inhaler, Rating Reiterated by Zacks, Matthew J. Pfeffer & More

Editor’s Note: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Merck & Co., Inc. (......(read more)
Ken Fisher - FISHER ASSET MANAGEMENT

Billionaire Ken Fisher’s Cheap Stock Picks for Q3 Include Microsoft Corporation (MSFT)

Several weeks after the end of each quarter, hedge funds and other notable investors including billionaire Ken Fisher’s mutual fund Fisher Asset Management......(read more)
AQR CAPITAL MANAGEMENT

Cliff Asness’s 3%+ Yield Investments Include AT&T Inc. (T)

In May, Cliff Asness’s AQR Capital Management filed its 13F for the first quarter of 2013 with the SEC. While the information on the specific number......(read more)
Ken Fisher - FISHER ASSET MANAGEMENT

Billionaire Ken Fisher’s Healthcare Picks for Q3 Include Pfizer Inc. (PFE)

In mid July, Fisher Asset Management, the asset management firm run by billionaire and Forbes columnist Ken Fisher, filed its 13F for the second quarter......(read more)
Irving Kahn

Kahn Brothers’s Top Stock Picks Include Citigroup Inc (C)

In May, Kahn Brothers, a hedge fund which has been managed by Irving and Thomas Kahn since 1978, filed their 13F for the first quarter of 2013 with the......(read more)

Billionaire Michael Price’s Cheap Stock Picks Include Pfizer Inc. (PFE)

We track quarterly 13F filings from hundreds of hedge funds and other notable investors as part of our work researching investment strategies; we have......(read more)
Stan Druckenmiller DUQUESNE CAPITAL

Billionaire Stanley Druckenmiller’s 3% Yield and Higher Picks Include Pfizer Inc. (PFE)

In May, billionaire Stanley Druckenmiller- the former manager of Duquesne Capital, though he may be better known as one of George Soros’s portfolio......(read more)
BLUE RIDGE CAPITAL

Brahman Capital Owns 5.7% of Endo Health Solutions Inc (ENDP)

A 13G filed with the SEC has disclosed that Brahman Capital, a hedge fund managed by Peter Hochfelder and his team, owns 6.3 million shares of Endo Health......(read more)
David Shaw

Billionaire David Shaw’s Cheap Stock Picks Include Apple Inc. (AAPL)

We track quarterly 13F filings from hundreds of hedge funds and other notable investors, including billionaire David Shaw’s large hedge fund D.E. Shaw......(read more)
BLUE RIDGE CAPITAL

Tiger Cub John Griffin’s Blue Ridge Capital Up to 6% of Endo Health Solutions Inc (ENDP)

Blue Ridge Capital, a hedge fund managed by John Griffin, has filed a 13G with the SEC to disclose a position of 6.6 million shares in Endo Health Solutions......(read more)
David Shaw

Philip Hempleman’s Top Stock Picks

Philip Hempleman founded Ardsley Partners in 1987. Connecticut-based Ardsley is a long/short equity hedge fund with approximately $1 billion under management......(read more)
Paul Singer ELLIOTT MANAGEMENT

Hedge Fund News: BarclayHedge, Marc Faber, Paul Singer

TrimTabs and BarclayHedge report hedge funds redeem $4.9bn in June 2012 (Opalesque) BarclayHedge and TrimTabs Investment Research reported today that......(read more)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

FDA Approval: End of Arena, VIVUS Running Out of Adrenaline?

The celebrations must be over. That was fast. Arena Pharmaceuticals (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS), the two companies that have recently gained......(read more)
BP plc (ADR) (NYSE:BP)

Tuesday Morning’s Notable Earnings: BP, Cummins, Deutsche Bank, Pfizer

After a relatively quiet Monday with earnings reports (fewer than 35 large-cap companies reported their earnings before and/or after the market yesterday......(read more)